Femasys, Inc. (FEMY)
0.5335
+0.03
(+5.02%)
USD |
NASDAQ |
Feb 09, 16:00
0.5335
0.00 (0.00%)
After-Hours: 16:53
Femasys EPS Diluted (Quarterly) : -0.1023 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Curis, Inc. | -0.4929 |
| LadRx Corp. | -1.453 |
| Plus Therapeutics, Inc. | -0.0412 |
| Windtree Therapeutics, Inc. | -1.085 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.195M |
| Revenue (Quarterly) | 0.7294M |
| Total Expenses (Quarterly) | 4.924M |
| Enterprise Value | 33.57M |
| Gross Profit Margin (Quarterly) | 30.78% |
| Profit Margin (Quarterly) | -575.1% |
| Earnings Yield | -135.0% |
| Normalized Earnings Yield | -135.01 |